(Q39629370)

13 September 2017

title

MMP-1-PAR1 axis mediates LPA-induced epithelial ovarian cancer (EOC) invasion (English)

1 reference

13 September 2017

1 reference

Feng-qiang Wang

1

1 reference

13 September 2017

Jessica Fisher

series ordinal

2

1 reference

13 September 2017

David A Fishman

series ordinal

3

1 reference

13 September 2017

language of work or name

English

0 references

publication date

20 November 2010

1 reference

13 September 2017

1 reference

13 September 2017

volume

120

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

247-255

1 reference

13 September 2017

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

The follow-up of ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Proteases in invasion: matrix metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

New functions for the matrix metalloproteinases in cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Strategies for MMP inhibition in cancer: innovations for the post-trial era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Matrix metalloproteinases and their inhibitors in gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Gene expression profiling predicts clinical outcome of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Molecular determinants of ovarian cancer plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

A polymorphism in the matrix metalloproteinase-1 gene promoter is associated with the prognosis of patients with ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Matrix metalloproteinase-1 promoter polymorphism and epithelial ovarian cancer: Does ethnicity matter?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Matrix metalloproteinases target protease-activated receptors on the tumor cell surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Protease-activated receptors: contribution to physiology and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Thrombin receptor overexpression in malignant and physiological invasion processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Lysophosphatidic acid is a bioactive mediator in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Cytokine-suppressive anti-inflammatory drugs (CSAIDs) inhibit invasion and MMP-1 production of ovarian carcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Immunologic relationship of a purified human skin collagenase to other human and animal collagenases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta 5 integrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

Role of thrombin receptor in breast cancer invasiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

p53 controls hPar1 function and expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

A genetically defined model for human ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.032

10.1016/J.YGYNO.2010.10.032

7 January 2021

Identifiers

DOI

1 reference

13 September 2017

1 reference